Studies in mice indicate that IL-25 inhibition can prevent airway hyperresponsiveness, reduce the production of T2 inflammation-related cytokines, decrease eosinophil infiltration, limit goblet cell hyperplasia, and lower serum IgE levels (146). Here, IGHE is linked to airway hyperresponsiveness.